BeOne Medicines(BEIGF)
CA - San CarlosBiotechnology
Focus: BeOne Medicines is a 12,000-person public biotech company headquartered in San Carlos, CA, focused on small molecules and monoclonal antibodies across oncology, nephrology, immunology, and dermatology. The company generates $2.5B in revenue (FY 2025) almost entirely from its flagship BTK inhibitor BRUKINSA.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
12,000
Open Jobs
290+14 this month
Growing — net +14 jobs in 30d
118 jobs added vs 104 removed. Steady team buildout.
Should You Work at BeOne Medicines?
AI assessmentBeOne offers solid near-term career stability with growing headcount and a meaningful pipeline, but the single-product revenue model and mounting losses present medium-term risk for job security and advancement opportunities.
Why Work Here
- Established revenue base of $2.5B with 78% YoY growth provides financial stability and R&D investment capacity at $1.8B annually
Data completeness
7/9 — Strong
Company HealthStrong
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$2.5B
Key Products
$801M Part DGrowing
Peak
Help build intelligence for BeOne Medicines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.